We report the observation and primary characterization of clinically isolated bacteria resistant to the antimicrobial agent imipemide (Nformimidoyl thienamycin [MK0787]), the stabilized derivative of a P-lactam molecule produced by Streptomyces cattleya. The 232, 1979) . Imipemide is resistant to ,-lactamases produced by a wide variety of bacterial strains and has been shown in vitro to inhibit the activity of several purified P-lactamases (12, 40) . Although many bacterial species have been screened for resistance to imipemide. only in Pseudomonas maltophilia has such resistance been found routinely (13, 15, 23, 24, 38, 41) .
The imipemide-resistant organisms reported here were predominantly coagulase-negative staphylococci, although the majority of the coagulase-negative staphylococci screened were susceptible to the drug. In some cases the resistance to imipemide appeared to be inducible, even in strains apparently constitutive for ampicillin and oxacillin resistance. In the absence of widespread use of imipemide, it is surprising to find a significant frequency of resistance to this antibiotic in a species that is usually susceptible to it. In response to these results, we have begun to investigate the nature of this imipemide resistance.
(A preliminary account of these findings was presented previously [R. Raeder, R. M. Blumenthal, C. D. Takemoto, and E. H. Freimer, Abstr. Annu. Meet. Am. Soc. Microbiol. 1983, I107, p. 157].) MATERIALS AND METHODS Bacterial strains. All strains were isolated from patients at the Medical College of Ohio Hospital between March and May 1982. Single-colony staphylococcal isolates were demonstrated to be gram-positive, catalase-positive cocci and were tested for coagulase activity. Coagulase-negative staphylococcal isolates were characterized further. Tentative species designations were determined through measuring the susceptibility of the isolates to novobiocin and lysostaphin (17) .
The novobiocin and lysostaphin were obtained from Sigma Chemical Co. (St. Louis, Mo.).
Antibiotics. Antibiotics used in Kirby-Bauer disk susceptibility assays included carbenicillin (100 ,ug), cephalothin (30 ,ug) , erythromycin (15 ,ug) , gentamicin (10~Lg), penicillin G (10 ,ug), and oxacillin (1 ,ug) Imipemide resistance in Pseudomonas species has been reported previously (13, 15, 23, 24, 38, 41) . However, the proportion of-coagulase-negative staphylococci found to show some pattern of imipemide resistance (8 of 25, or 32%) was unexpected and prompted further studies.
Comparison of imipemideresistant and -susceptible staphylococci. Antibiotic resistance profiles and preliminary species identification of the 25 isolates of coagulase-negative staphylococci were determined. No clear correlation could be made between resistance or susceptibility to imipemide and any other trait. All of the isolates appeared to be either Staphylococcus epidermidis (12 of 25) or Staphylococcus simulans, and both species were represented in the imipemideresistant and -susceptible groups. All of the imipemide-resistant strains were also resistant to penicillin, ampicillin, oxacillin, carbenicillin, moxalactam, ticarcillin, ceftizoxime, and erythromycin, but not all strains resistant to these antibiotics were also resistant to inmpemide. Nor was any correlation evident between imipemide resistance and resistance to cephalothin, gentamicin, tetracycline, vancomycin, mercury, or cadmium.
The frequencies of resistance to various antibiotics among those 25 isolates were not grossly different from the frequencies measured, for a larger group of coagulase-negative staphylococci, by the clinical microbiology laboratory at the Medical College of Ohio Hospital. Those frequencies that did differ significantly between the two collections of staphylococci were not due to differences between imipemide-resistant and -susceptible strains. (Fig. 3 and 4) . As expected, the growth of Imi5 cultures-rapidly slowed in response to as little as 0.5 p,g of imipemide per ml, and after about 1 h the turbidity of the culture began to decrease exponentially (Fig.  3A) . Such cultures never resumed growth, nor could live staphylococci be rovOWd by dilution and plating. In contrast-, the wni culture showed a concentrat_4ependes_`e to the drug (Fig. 3B-ad 4A ). S subMIC concentrations of ipe r.duce a pronounced pause in the :hb cultures (Fig. 3B) been found to be a simple functon of the presence or absence of a -lactamase active against that drug (25, 32, 39) .
In staphylococci, resistance to P-lactam antibiotics is generally due to four ,B-lactamases, usually specified by plasmid-borne genes (25) . The A, B, and C 3-lactamases are inducible, whereas the 1-type ,B-lactamase seems to be expressed constitutively (29) . Thus, the D-type ,3-lactamase is probably not involved in the resistance of Imidz isolates to imipemide. No isolates of Staphylococcus aureus have been reported to be resistant to imipemide (13, 15, 23, 38, 41) . Thus, the common A-, B-, and C-type Plactamases are probably not solely responsible for the imipemide resistance either. The other major form of resistance to ,-lactam agents found in the staphylococci is the intrinsic resistance to methicillin (18, 19, 31) . Methicillin resistance in S. aureus is not due to a P-lactamase,, although the enzyme can play a peripheral role (30, 37) . This methicillin resistance has been found to be constitutive (5) . Whereas all of the coaglase-negative staphylococci found to be imipetnide resistant were also resistant to methiciUlin (oxacillin), several of the imipemide-susceptible strains were also resistant to oxacillin.
Furthermore, other studies report meteilnresistant staphylococci to be susceptible to imipemide (21, 23) . Thus it is possible that the imipemide resistance in these coagulase-negative staphylococci is not directly due to either the known staphylococcal ,-lactamases or to the methicillin resistance system. NW of ld etd f. Twvo patterns of imipemide resistance were found in the coagulase-negative staphylococci. One pattern appears to be a constitutive expression. In growth experiments there were no de.tectable pauses in the growth of Imil isolates after the addition of imipemide. This pattern could, alternatively, be due to the rapid induction of a fastacting resistance mechanism, but this seems less likely.
The second pattemn of imipemide resistance seems to be due to an inducible system. The growth-shift experiments indicate that a pause in growth occurs after a short period ofexposure to iimipemide, and then eventually growth resumes ( Fig. 3 and 4) . This phenomenon is highly dependent on the concentration of the drug. The pattern of growth around an imipeinide disk suggests that the concentratiok of the drug sufficient to induce the resistance mechanism is higher than the MIC of that drug. Interestingly, ampicillin and ticarcillin appear to affect the expression of imipeide ance ( Fig. IA The plasmid profiles of these Imis derivatives appeared to be identical to those of the parent strains, and some of the derivatives may have resulted from the mutagenic action of ethidium bromide and acridine orange. The coagulase-negative staphylococci have considerable clinical significance in their own right (16, 22, 26, 43) . Their importance may also extend to acting as a conduit for genes between VOL. 24, 1983 on October 18, 2017 by guest http://aac.asm.org/ Downloaded from the soil microorganisms (27) and a wide range of other organisms, possibly including Bacillus subtilis (10) , Streptococcus pneumoniae (1), E. coli (1), other staphylococci (4, 18) , and even Saccharomyces cerevisiae (11) . The mechanism, regulation, and epidemiology of imipemide resistance in the coagulase-negative staphylococci have yet to be clearly established. The results of such studies may well indicate the means by which an antibiotic resistance gene moves into clinically significant microorganisms before the industrial production and use of the relevant antibiotic.
